Court Revives Zoll Product Safety Suit Following Earlier Premption Ruling
Executive Summary
The Eleventh Circuit Court of Appeals reversed a lower court's decision that US FDA regulations pre-empted a product liability suit against Zoll Medical. The suit was filed by the son of a woman who allegedly died after her Zoll LifeVest external defibrillator malfunctioned.
You may also be interested in...
Warning Letter Roundup & Recap
Zoll cited for QS and MDR violations; FDA instructs maker of drug-of-abuse kits to hire a consultant to audit the firm’s manufacturing and quality assurance systems; Ambco Electronics failed to fully investigate and document device failures. Eight quality-related warning letters were listed by FDA from Sept. 12 through Oct. 14.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.